Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Impact of Montelukast, SPM, and/or Almond/Almond Oil Supplementation on Lipid Mediator Biosynthesis in Colorectal, Sarcomas, Brain Tumors, Endometrial, and Ovarian Cancer: A Pilot Study

NCT06887673 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT06887673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06887673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Impact of Montelukast, SPM, and/or Almond/Almond Oil Supplementation on Lipid Mediator Biosynthesis in Colorectal, Sarcomas, Brain Tumors, Endometrial, and Ovarian Cancer: A Pilot Study
Lead sponsor
University of South Florida
Phase
Phase 1
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
March 31, 2026
Enrollment
56 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors, colorectal cancer, endometrial cancer, ovarian cancer, sarcoma